---
schema_version: "secwatch.filing_event.v1"
accession: "0001161697-24-000423"
form_type: "8-K"
ticker: null
cik: "0001502152"
company_name: "GlobeStar Therapeutics Corp"
filed_at: "2024-10-28T23:59:59+00:00"
generated_at: "2026-05-30T09:39:11.629918+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# CFO Robert Chicoski resigns from GlobeStar Therapeutics effective Aug 8, 2024

## Summary
- CFO Robert Chicoski resigned all officer roles, including principal financial & accounting officer, effective August 8, 2024.
- Resignation was not due to any disagreement with the company.
- No successor or interim CFO has been announced as of the filing date.

## SEC filing metadata
- accession: 0001161697-24-000423
- form_type: 8-K
- cik: 0001502152
- company_name: GlobeStar Therapeutics Corp
- filed_at: 2024-10-28T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: medium
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1502152/000116169724000423/0001161697-24-000423-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1502152/000116169724000423/form_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001161697-24-000423
- JSON: https://secwatch.observer/filing/0001161697-24-000423.json
- Plain text: https://secwatch.observer/filing/0001161697-24-000423.txt

## Key facts
- Executive change
  Robert Chicoski resigned as Chief Financial Officer at GlobeStar Therapeutics Corp.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On August 8, 2024, GlobeStar Therapeutics Corporation, a Wyoming corporation (the “Company”) received notice of the resignation of Robert Chicoski as Chief Financial Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1502152/000116169724000423/0001161697-24-000423-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.